One Health

One Health is an initiative to improve animal and human health globally through collaboration between veterinarians, physicians, osteopaths, dentists, nurses, and other scientific-health professionals. It recognizes that the health of people is closely connected to the health of animals and our shared environment. The study of emerging infectious diseases, the effects of pollution and antibiotic resistance, the value of the human-animal bond, and more are critical to ensuring optimal health and well-being for all species. To promote One Health, the AKC Canine Health Foundation recognizes and supports research that improves the health of dogs while simultaneously advancing knowledge for human medicine.
CHF-funded studies with a One Health impact are denoted with the following symbol on our website and in our Research Grants Portfolio:

Click here to learn more about the One Health Commission.
Explore the November 2021 issue of Human Genetics - a special issue on companion animal genetics which highlights research by several AKC Canine Health Foundation funded investigators.
Resources
One Health Articles
One Health: A Shortcourse
(courtesy of the Canine Chronicle, June 2021)
Items 66 - 9 of 9 | Previous |
One Health Research Grants
02502 | Precision Medicine for Canine Lymphoma |
02500 | Immune Targeting of the V600E B-Raf Neoantigen in Canine Urothelial Carcinoma |
02448 | Canine Chagas Disease: Characterizing Cardiac Abnormalities, Vector Infection and Control Strategies, and Parasite Strains in Kennel Environments |
02461-A | Innate immune response to Leptospira in naturally exposed dogs |
02404-A | The Impact of Lidocaine Administration on Natural Killer Cell Populations in Canine Sepsis |
02383 | Identifying Cellular Mechanisms of Inflammation During Canine Tick‐Borne Diseases |
02380-A | Estimating Prevalence and Identifying Risk Factors for Canine Leptospirosis in North America |
02322 | Analysis of the Health, Behavioral, and Longevity Data Collected in the 9/11 Medical Surveillance Longitudinal Study |
02321 | Clinical Trial of Procaspase-3 Activator (PAC-1) in Combination with Hydroxyurea for Treatment of Canine Meningioma |
02309-T | Targeting the Cancer Epigenome: The Effect of Specific Histone Lysine Methyltransferase Inhibition in Canine B-Cell Lymphoma |
How to Help
Support CHF-funded research. The knowledge gained will help improve the health of dogs and humans.
Help Future Generations of Dogs
Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.